Laurus Labs Invests in Joint Venture KRKA Pharma, Subsidiary Laurus Bio

MT Newswires Live2025-12-24

Laurus Labs (NSE:LAURUSLABS, BOM:540222) said it has invested 490 million Indian rupees to acquire 49 million equity shares in joint venture, KRKA Pharma, through a rights issue, according to an Indian bourse filing on Tuesday.

The shares were acquired at a face value of 10 rupees each, the filing said.

The company also invested 350 million rupees in subsidiary, Laurus Bio, through the allotment of 13,487 Series A3 compulsorily convertible preference shares on a private placement-cum-preferential basis, according to a separate disclosure on Tuesday.

Following the transaction, Laurus Labs' shareholding in Laurus Bio stands at 75.61% on a fully diluted basis, the disclosure said.

Laurus Labs shares rose over 1% in early Wednesday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2593042628?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-24 12:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593042628","market":"sg","top_or_hot":-1,"title":"Laurus Labs Invests in Joint Venture KRKA Pharma, Subsidiary Laurus Bio","media":"MT Newswires Live","content":"<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) said it has invested 490 million Indian rupees to acquire 49 million equity shares in joint venture, KRKA Pharma, through a rights issue, according to an Indian bourse filing on Tuesday.</p><p>The shares were acquired at a face value of 10 rupees each, the filing said.</p><p>The company also invested 350 million rupees in subsidiary, Laurus Bio, through the allotment of 13,487 Series A3 compulsorily convertible preference shares on a private placement-cum-preferential basis, according to a separate disclosure on Tuesday.</p><p>Following the transaction, Laurus Labs' shareholding in Laurus Bio stands at 75.61% on a fully diluted basis, the disclosure said.</p><p>Laurus Labs shares rose over 1% in early Wednesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Laurus Labs Invests in Joint Venture KRKA Pharma, Subsidiary Laurus Bio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLaurus Labs Invests in Joint Venture KRKA Pharma, Subsidiary Laurus Bio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-24 12:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) said it has invested 490 million Indian rupees to acquire 49 million equity shares in joint venture, KRKA Pharma, through a rights issue, according to an Indian bourse filing on Tuesday.</p><p>The shares were acquired at a face value of 10 rupees each, the filing said.</p><p>The company also invested 350 million rupees in subsidiary, Laurus Bio, through the allotment of 13,487 Series A3 compulsorily convertible preference shares on a private placement-cum-preferential basis, according to a separate disclosure on Tuesday.</p><p>Following the transaction, Laurus Labs' shareholding in Laurus Bio stands at 75.61% on a fully diluted basis, the disclosure said.</p><p>Laurus Labs shares rose over 1% in early Wednesday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健护理机构","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2593042628","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593042628","pubTimestamp":1766551859,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Laurus Labs  said it has invested 490 million Indian rupees to acquire 49 million equity shares in joint venture, KRKA Pharma, through a rights issue, according to an Indian bourse filing on Tuesday.The shares were acquired at a face value of 10 rupees each, the filing said.The company also invested 350 million rupees in subsidiary, Laurus Bio, through the allotment of 13,487 Series A3 compulsorily convertible preference shares on a private placement-cum-preferential basis, according to a separate disclosure on Tuesday.Following the transaction, Laurus Labs' shareholding in Laurus Bio stands at 75.61% on a fully diluted basis, the disclosure said.Laurus Labs shares rose over 1% in early Wednesday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","JYNT":"The Joint Corp."},"translate_title":"Laurus Labs投资合资企业KRKA Pharma、子公司Laurus Bio","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JYNT":1.5},"content_text":"Laurus Labs (NSE:LAURUSLABS, BOM:540222) said it has invested 490 million Indian rupees to acquire 49 million equity shares in joint venture, KRKA Pharma, through a rights issue, according to an Indian bourse filing on Tuesday.The shares were acquired at a face value of 10 rupees each, the filing said.The company also invested 350 million rupees in subsidiary, Laurus Bio, through the allotment of 13,487 Series A3 compulsorily convertible preference shares on a private placement-cum-preferential basis, according to a separate disclosure on Tuesday.Following the transaction, Laurus Labs' shareholding in Laurus Bio stands at 75.61% on a fully diluted basis, the disclosure said.Laurus Labs shares rose over 1% in early Wednesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2593042628","isCrawlerRequest":true}